Ligand Pharmaceuticals Inc (LGND) stock
LGNDNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as LGNDZ, LGNXZ, LGNYZ, LGNZZ
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 6/30433% above fair value
$298.71+4.90 (+1.67%)
Close on Nov 18, 2026Market cap $5.98BP/E 130.4Yield –
Ligand Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ligand Pharmaceuticals's market cap was $6.31B on Nov 11, 2026, against $3.99B a year earlier. Over the last 5 years it ranged from $907.34M to $6.43B, with a median of $1.91B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.31B | +69.8% |
| 2025 | Dec 31, 2025 | $3.72B | +84.9% |
| 2024 | Dec 31, 2024 | $2.01B | +61.6% |
| 2023 | Dec 29, 2023 | $1.24B | +10.3% |
| 2022 | Dec 30, 2022 | $1.13B | -56.3% |
| 2021 | Dec 31, 2021 | $2.58B | +61.3% |
| 2020 | Dec 31, 2020 | $1.60B | +87266.7% |
| 2019 | Dec 31, 2019 | $1.83M | -99.9% |
| 2018 | Dec 31, 2018 | $2.86B | -0.9% |
| 2017 | Dec 29, 2017 | $2.89B | +36.0% |
| 2016 | Dec 30, 2016 | $2.12B | -1.7% |
| 2015 | Dec 31, 2015 | $2.16B | +101.7% |
| 2014 | Dec 31, 2014 | $1.07B | -5.5% |
| 2013 | Dec 31, 2013 | $1.13B | +159.0% |
| 2012 | Dec 31, 2012 | $437.25M | +87.5% |
| 2011 | Dec 30, 2011 | $233.18M | +38.6% |
| 2010 | Dec 31, 2010 | $168.26M | – |
See a number that looks wrong?